Related Experiment Video
Updated: May 2, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.4K
Long-term diabetic response to gastric bypass
Stephen W Davies1, Jimmy T Efird2, Christopher A Guidry1
1Department of General Surgery, University of Virginia School of Medicine, Charlottesville, Virginia.
The Journal of Surgical Research
|February 26, 2014
Summary
Gastric bypass surgery leads to significant weight loss and improved diabetes control in obese patients. While long-term diabetes remission rates vary, responsive patients show greater weight loss and lower HbA1c levels.
Area of Science:
- Bariatric surgery
- Endocrinology
- Metabolic disease management
Background:
- Rising rates of obesity and type II diabetes necessitate effective long-term treatment solutions.
- Bariatric surgery is a viable option, but long-term outcome data for diabetic patients remain limited.
Purpose of the Study:
- To evaluate the long-term efficacy of gastric bypass surgery in achieving diabetic remission.
- To analyze factors influencing diabetic response and remission after bariatric procedures.
Main Methods:
- Retrospective cohort study of 707 diabetic patients undergoing gastric bypass from 1998-2012.
- Patients categorized by postoperative diabetic response (remission vs. refractory).
- Follow-up at 1, 3, 5, and 10 years, analyzed using t-tests, Wilcoxon rank-sum, and Cox regression models.
Main Results:
- Diabetic response rates were 56% (1 yr), 58% (3 yr), 60% (5 yr), and 44% (10 yr).
- Responsive patients achieved greater weight loss and lower hemoglobin A1c levels.
- Decreasing age and body mass index correlated with increased diabetic cure rates.
Conclusions:
- Gastric bypass leads to substantial weight loss and improved glycemic control in diabetic patients.
- Long-term remission rates vary, highlighting the need for optimized preoperative care and follow-up strategies.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:36Carbohydrate Metabolism
10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
01:24Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K